Filter Results:
(954)
Show Results For
- All HBS Web
(1,400)
- People (1)
- News (290)
- Research (954)
- Events (6)
- Multimedia (2)
- Faculty Publications (284)
Show Results For
- All HBS Web
(1,400)
- People (1)
- News (290)
- Research (954)
- Events (6)
- Multimedia (2)
- Faculty Publications (284)
Sort by
- 04 Nov 2014
- Working Paper Summaries
Making the Numbers? ‘Short Termism’ & the Puzzle of Only Occasional Disaster
- Article
How to Really Motivate Salespeople
By: Doug J. Chung
Much of what we believe about the best ways to compensate and motivate the sales force is based on theory and lab experiments. But in the past decade, researchers have been moving out of the lab and into the field, analyzing companies' sales and pay data, and... View Details
Keywords: Compensation; Motivating People; Motivation and Incentives; Compensation and Benefits; Sales
Chung, Doug J. "How to Really Motivate Salespeople." Harvard Business Review 93, no. 4 (April 2015): 54–61.
- April 2014 (Revised June 2014)
- Case
Wawa Inc.
By: Blythe J. McGarvie, Dennis Campbell and Kristin Stack
Retailing requires attention to detail and customer and employee loyalty. Wawa is a 50-year old food retailer with almost a cult-like following. With $9 billion in revenues, Wawa is the 50th largest privately-held company in the US. Learn how they have accomplished... View Details
McGarvie, Blythe J., Dennis Campbell, and Kristin Stack. "Wawa Inc." Harvard Business School Case 114-086, April 2014. (Revised June 2014.)
- April 1997
- Case
Battle of Mannheim, The
By: Hugo Uyterhoeven
Focuses in detail on implementing a corporate restructuring program in ABB's German subsidiary. Special attention is given to Germany's unique form of industrial governance. Two major problem areas--power plants and power transformers--are described in detail, as is a... View Details
Keywords: Corporate Governance; Energy Generation; Salesforce Management; Business or Company Management; Restructuring; Programs; Energy Industry; Germany
Uyterhoeven, Hugo. "Battle of Mannheim, The." Harvard Business School Case 397-098, April 1997.
- October 2019
- Case
A Conversation with Ellen J. Kullman, Chairman & CEO of DuPont, 2009-2015
By: Lynn S. Paine and Will Hurwitz
Ellen J. Kullman, the retired Chairman and CEO of DuPont, describes how she guided the storied science and technology company through a contentious proxy battle with activist investor Trian Partners, which acquired DuPont shares in 2013 and sought to break up the... View Details
Keywords: Agribusiness; Capital Structure; Corporate Accountability; Corporate Governance; Institutional Investing; Leadership; Leadership Style; Management; Transformation; Agriculture and Agribusiness Industry; Chemical Industry; United States
Paine, Lynn S., and Will Hurwitz. "A Conversation with Ellen J. Kullman, Chairman & CEO of DuPont, 2009-2015." Harvard Business School Case 320-017, October 2019.
- August 1998
- Case
Electronic Commerce at Air Products
By: F. Warren McFarlan and Melissa Dailey
In 1998,chief information officers (CIOs) in the highly competitive international gases and chemicals business faced the reality that electronic commerce capability was a strategic necessity. The results of annual surveys of technology officers in the chemical industry... View Details
Keywords: Management Teams; Information Technology; Globalized Markets and Industries; Infrastructure; Internet and the Web; Technology Adoption; Business Strategy; Chemical Industry; United States
McFarlan, F. Warren, and Melissa Dailey. "Electronic Commerce at Air Products." Harvard Business School Case 399-035, August 1998.
- 14 Nov 2007
- Research & Ideas
Growing CEOs from the Inside
There is no more important decision a board can make than naming a CEO. Yet most companies pay scant attention to the issue of succession other than a few whispered names in the hallways. The result? The hiring of an outsider who quickly... View Details
- 20 Oct 2011
- Research & Ideas
Getting the Marketing Mix Right
Businesses rely on solid marketing strategies to boost sales—yet the tools used to evaluate these strategies often provide misleading results, leaving managers with the inability to accurately measure how they can get the best bang for... View Details
Keywords: by Dina Gerdeman
- 05 Sep 2023
- Book
Failing Well: How Your ‘Intelligent Failure’ Unlocks Your Full Potential
results. “An intelligent failure is an undesired result in new territory,” says Edmondson, the Novartis Professor of Leadership and Management at HBS. “There’s no way you can know for sure whether it will work out without trying it.”... View Details
Keywords: by Michael Blanding
- 30 Mar 2020
- Research & Ideas
The New Rules for Remote Work: Pandemic Edition
personal level, for instance, by asking how everyone is holding up. “It can be harder to pay attention to a long meeting online versus face-to-face.” Afterward, managers should articulate key outcomes of the... View Details
Keywords: by Dina Gerdeman
- 2024
- Working Paper
Digital Platforms 2.0: Learnings, Opportunities, and Challenges
By: Shrabastee Banerjee, Ishita Chakraborty, Hana Choi, Hannes Datta, Remi Daviet, Chiara Farronato, Minkyung Kim, Anja Lambrecht, Puneet Manchanda, Aniko Oery, Ananya Sen, Marshall W Van Alstyne, Prasad Vana, Kenneth C Wilbur, Xu Zhang and Bobby Zhou
Platform-based digital ecosystems form the backbone of our interactions with the Internet. Over the past decade, digital ecosystems have witnessed significant growth, both in terms of industry footprint and academic research. Yet, the challenges associated with their... View Details
Banerjee, Shrabastee, Ishita Chakraborty, Hana Choi, Hannes Datta, Remi Daviet, Chiara Farronato, Minkyung Kim, Anja Lambrecht, Puneet Manchanda, Aniko Oery, Ananya Sen, Marshall W Van Alstyne, Prasad Vana, Kenneth C Wilbur, Xu Zhang, and Bobby Zhou. "Digital Platforms 2.0: Learnings, Opportunities, and Challenges." Working Paper, June 2024.
- 19 Sep 2005
- Research & Ideas
Rethinking Company Loyalty
companies are willing to rethink how they define loyalty and how they manage their people. Reevaluating Loyalty Loyalty should not be viewed as an either/or proposition. It's true, the experts say, that to produce their best work,... View Details
Keywords: by Lauren Keller Johnson
- 31 Aug 2010
- First Look
First Look: August 31
attention has been given to how managers can effectively allocate work across tasks and time to improve workers' performance. In this paper, we use the learning curve framework to investigate how... View Details
Keywords: Sean Silverthorne
- February 2015 (Revised November 2015)
- Case
Building an Integrated Biopharma Company: Crucell (A)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing; Licensing Agreements In Biopharmacy; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Partners and Partnerships; Entrepreneurship; Growth and Development Strategy; Biotechnology Industry; Pharmaceutical Industry; Netherlands
Hamermesh, Richard G., Marianne Van Der Steen, and Susan S. Harmeling. "Building an Integrated Biopharma Company: Crucell (A)." Harvard Business School Case 815-085, February 2015. (Revised November 2015.)
- June 2021
- Article
Deals in the Time of Pandemic
By: Guhan Subramanian and Caley Petrucci
The COVID-19 pandemic has brought new attention to the period between signing and closing in M&A transactions. Transactional planners heavily negotiate the provisions that govern the behavior of the parties during this window, not only to allocate risk between the... View Details
Subramanian, Guhan, and Caley Petrucci. "Deals in the Time of Pandemic." Columbia Law Review 121, no. 5 (June 2021): 1405–1480.
- 20 May 2009
- Working Paper Summaries
On Good Scholarship, Goal Setting, and Scholars Gone Wild
- January 2009 (Revised February 2009)
- Case
Pitney Bowes: Employer Health Strategy
By: Michael E. Porter and Jennifer F Baron
Pitney Bowes, a Fortune 500 mail and document management firm, offered its first health plans in the years following World War II. Over the ensuing decades, Pitney Bowes adapted its approach to employee health amid rising health care costs, shifting employer attitudes... View Details
Keywords: Cost; Insurance; Policy; Health Care and Treatment; Compensation and Benefits; Employees; Corporate Strategy
Porter, Michael E., and Jennifer F Baron. "Pitney Bowes: Employer Health Strategy." Harvard Business School Case 709-458, January 2009. (Revised February 2009.)
- Research Summary
Overview
By: Jorge Tamayo
Professor Tamayo’s research focuses on theoretical modeling and structural estimation of firm decision-making and productivity.
Professor Tamayo studies dynamic competition for customer membership. Generally, firms that implement a membership model charge a... View Details
Professor Tamayo studies dynamic competition for customer membership. Generally, firms that implement a membership model charge a... View Details
- November 2006 (Revised March 2012)
- Case
Clocky: The Runaway Alarm Clock
By: Elie Ofek and Eliot Sherman
Gauri Nanda is the creator of an innovative new product: an alarm clock named Clocky that, in addition to ringing, rolls around the room in order to force its owner to get out of bed. Beset by media attention and consumer interest but still at least a year away from... View Details
Keywords: Management; Product Positioning; Partners and Partnerships; Production; Marketing Strategy; Media; Entrepreneurship; Independent Innovation and Invention; Product Launch
Ofek, Elie, and Eliot Sherman. "Clocky: The Runaway Alarm Clock." Harvard Business School Case 507-016, November 2006. (Revised March 2012.)
- 2007
- Article
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation
By: Arthur A. Daemmrich
In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative... View Details
Keywords: Brands and Branding; Policy; Risk Management; Government Legislation; Risk and Uncertainty; Goals and Objectives; Customers; Pharmaceutical Industry; Health Industry; United States
Daemmrich, Arthur A. "Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation." Pharmacy in History 49, no. 2 (2007): 61–75.